Published in J Virol on May 01, 1998
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol (1998) 4.52
Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol (2005) 2.94
A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 2.64
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol (2003) 2.60
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol (2002) 2.26
Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol (1999) 1.96
Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol (2006) 1.87
Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol (2001) 1.84
Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol (1999) 1.72
TNF-induced signaling in apoptosis. J Clin Immunol (1999) 1.71
Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol (2004) 1.67
Genetics of hepatocellular carcinoma. World J Gastroenterol (2007) 1.64
Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol (1999) 1.63
Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol (1999) 1.63
Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol (2008) 1.60
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene (2011) 1.56
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J (2000) 1.49
Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species. J Gastroenterol (2006) 1.47
Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol (1999) 1.45
Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol (1999) 1.45
Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol (2004) 1.40
Hepatitis C virus infection and apoptosis. World J Gastroenterol (2007) 1.36
Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog (2006) 1.34
Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One (2009) 1.33
Rubella virus capsid associates with host cell protein p32 and localizes to mitochondria. J Virol (2000) 1.32
Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology (2003) 1.32
Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts. J Virol (2004) 1.30
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J Virol (2002) 1.22
Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci (2005) 1.21
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis (2003) 1.20
Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol (2006) 1.19
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol (2005) 1.16
Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. PLoS One (2011) 1.16
Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol (2000) 1.14
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol (2003) 1.13
Identification of residues in the hepatitis C virus core protein that are critical for capsid assembly in a cell-free system. J Virol (2005) 1.08
Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol (2002) 1.05
Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase. Mol Cell Biol (2006) 1.00
Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases. Viruses (2012) 0.97
Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame. Am J Pathol (2007) 0.96
Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells. Antimicrob Agents Chemother (2003) 0.95
Access of viral proteins to mitochondria via mitochondria-associated membranes. Rev Med Virol (2009) 0.95
Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J Clin Virol (2004) 0.94
Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J Virol (2001) 0.94
Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity. J Virol (2002) 0.94
Chronic hepatitis C. Gut Liver (2011) 0.94
Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy. J Virol (2011) 0.92
Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol (2001) 0.92
Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol (2006) 0.91
HCV-related nervous system disorders. Clin Dev Immunol (2012) 0.90
Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis. PLoS One (2014) 0.90
Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein. J Virol (2000) 0.89
Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol (2008) 0.88
TLRs, Alcohol, HCV, and Tumorigenesis. Gastroenterol Res Pract (2011) 0.88
Microbes-induced EMT at the crossroad of inflammation and cancer. Gut Microbes (2012) 0.87
Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells. World J Gastroenterol (2004) 0.87
A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans. Trans Am Clin Climatol Assoc (2000) 0.85
Production and pathogenicity of hepatitis C virus core gene products. World J Gastroenterol (2014) 0.85
Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Hepat Res Treat (2010) 0.84
Hepatitis C virus core protein induces apoptosis-like caspase independent cell death. Virol J (2009) 0.83
Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice. World J Gastroenterol (2007) 0.82
Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir Res (2005) 0.81
Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV. J Clin Immunol (2005) 0.81
Hepatitis C virus and its roles in cell proliferation. J Gastroenterol (2002) 0.81
Hepatitis C virus non-structural 5A protein can enhance full-length core protein-induced nuclear factor-kappaB activation. World J Gastroenterol (2005) 0.80
Hepatitis C virus and hepatocellular carcinoma. Biology (Basel) (2013) 0.80
Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings? Hepat Mon (2012) 0.79
Hepatitis C virus core proteins derived from different quasispecies of genotype 1b inhibit the growth of Chang liver cells. World J Gastroenterol (2008) 0.79
Alternate reading frame protein (F protein) of hepatitis C virus: paradoxical effects of activation and apoptosis on human dendritic cells lead to stimulation of T cells. PLoS One (2014) 0.78
Systemic abnormalities in liver disease. World J Gastroenterol (2009) 0.78
Acute hepatitis C in a chronically HIV-infected patient: evolution of different viral genomic regions. World J Gastroenterol (2003) 0.78
Hepatitis C Virus Infection Is Associated With an Increased Risk of Active Tuberculosis Disease: A Nationwide Population-Based Study. Medicine (Baltimore) (2015) 0.77
Oxidative stress and apoptosis in hepatitis C: the core issue. J Gastroenterol (2006) 0.77
CD4+ and CD19+ splenocytes undergo apoptosis during an experimental murine infection with Taenia crassiceps. Parasitol Res (2003) 0.77
Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study. Eur J Pediatr (2013) 0.76
Progression of viraemia during treatment with infliximab in a patient with rheumatoid arthritis and chronic hepatitis C infection. BMJ Case Rep (2009) 0.76
Functional characterization of core genes from patients with acute hepatitis C virus infection. J Infect Dis (2010) 0.76
Cellular immune response to infection by different genotypes of hepatitis C virus. Indian J Clin Biochem (2009) 0.76
Hepatitis C virus and neurological damage. World J Hepatol (2016) 0.75
The suppression effects of desacetyluvaricin on hepatocellular carcinoma and its possible mechanism. Pharmacogn Mag (2012) 0.75
Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas. J Dig Dis Hepatol (2016) 0.75
Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis. Clin Rheumatol (2004) 0.75
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
NF-kappa B: ten years after. Cell (1996) 12.80
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (1996) 11.29
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell (1995) 9.81
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell (1996) 9.68
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell (1996) 8.89
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell (1995) 8.80
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell (1995) 5.97
A novel domain within the 55 kd TNF receptor signals cell death. Cell (1993) 5.59
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (1995) 4.95
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
Serum levels of cytokines in chronic liver diseases. Gastroenterology (1992) 3.47
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med (1996) 2.93
The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology (1992) 2.88
Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods (1984) 2.38
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol (1996) 2.25
Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene (1990) 2.14
Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol (1996) 2.02
Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene (1996) 1.96
Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem (1990) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci U S A (1995) 1.81
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology (1994) 1.80
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med (1994) 1.66
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res (1995) 1.58
Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology (1996) 1.56
Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology (1997) 1.49
Tumorigenicity and lysis by natural killers. J Exp Med (1981) 1.43
Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol (1997) 1.42
Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol (1995) 1.27
Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med (1994) 1.23
Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J Cell Biochem (1993) 1.22
Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology (1994) 1.21
Characterization of HCV structural proteins expressed in various animal cells. Intervirology (1994) 1.07
Structural proteins of hepatitis C virus. Trends Microbiol (1993) 1.03
Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol (1994) 1.03
Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol (1994) 0.97
Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases. J Clin Pathol (1989) 0.90
Hepatitis C virus and hepatocellular carcinoma. Clin Exp Rheumatol (1996) 0.79
Lymphotoxin-beta and TNF regulation in T cell subsets: differential effects of PGE2. Cytokine (1997) 0.79
Hepatitis C and liver transplantation. J Gastroenterol Hepatol (1996) 0.79
Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins (1991) 32.50
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
Selection of representative protein data sets. Protein Sci (1992) 15.62
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
The HSSP database of protein structure-sequence alignments and family profiles. Nucleic Acids Res (1998) 9.59
Rb targets histone H3 methylation and HP1 to promoters. Nature (2001) 8.26
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
PHD--an automatic mail server for protein secondary structure prediction. Comput Appl Biosci (1994) 6.71
Essential role of Stat6 in IL-4 signalling. Nature (1996) 6.56
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell (1995) 5.97
Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J (2000) 5.61
Correlated mutations and residue contacts in proteins. Proteins (1994) 5.20
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (2001) 4.18
Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol (2000) 4.10
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (1988) 4.04
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Why patients choose paracetamol for self poisoning and their knowledge of its dangers. BMJ (1995) 3.86
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem (2001) 3.70
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A (2001) 3.49
Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med (1985) 3.48
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J (1999) 3.42
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38
Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. Proc Natl Acad Sci U S A (1981) 3.28
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Paracetamol self-poisoning. Characteristics, prevention and harm reduction. Br J Psychiatry (1996) 3.07
Concerns about game ranching. Can Vet J (1990) 3.07
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol (1987) 2.99
Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem (1983) 2.97
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Polarization of the Golgi apparatus and the microtubule-organizing center within cloned natural killer cells bound to their targets. Proc Natl Acad Sci U S A (1983) 2.85
IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol (1999) 2.84
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol (1997) 2.79
Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes. J Exp Med (1983) 2.78
'Ischemic tolerance' phenomenon found in the brain. Brain Res (1990) 2.73
STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A (1996) 2.64
Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature (1983) 2.62
Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol (1998) 2.59
Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J Biol Chem (2000) 2.58
Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature (1994) 2.57
Effects of oleate starvation in a fatty acid auxotroph of Escherichia coli K-12. J Bacteriol (1969) 2.53
Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature (1978) 2.51
Protein fold recognition by prediction-based threading. J Mol Biol (1997) 2.51
Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations. Cell Immunol (1980) 2.47
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem (2001) 2.45
A sensitive and rapid gel retention assay for nuclear factor I and other DNA-binding proteins in crude nuclear extracts. Nucleic Acids Res (1986) 2.45
The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35
Progress in protein structure prediction? Trends Biochem Sci (1993) 2.34
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke (1998) 2.34
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol (1998) 2.32
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
The use of a token system in project Head Start. J Appl Behav Anal (1970) 2.20
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity (2000) 2.16
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors. Infect Immun (2000) 2.10
Reorientation of the microtubule-organizing center and the Golgi apparatus in cloned cytotoxic lymphocytes triggered by binding to lysable target cells. J Immunol (1984) 2.09
Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst (1968) 2.08
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
Translation of the structural genes of the E. coli pyruvate dehydrogenase complex. Cold Spring Harb Symp Quant Biol (1966) 2.06
Bacterial community associated with Pfiesteria-like dinoflagellate cultures. Environ Microbiol (2001) 2.06
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04
MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet (2001) 2.04
Lymphotoxin-alpha (LTalpha) supports development of splenic follicular structure that is required for IgG responses. J Exp Med (1997) 1.99
First pass annotation of promoters on human chromosome 22. Genome Res (2001) 1.99
Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care (1992) 1.97
A supernova origin for dust in a high-redshift quasar. Nature (2004) 1.97
The HSSP database of protein structure-sequence alignments. Nucleic Acids Res (1994) 1.96